Cameron Brownمشاهده پروفایل
دانشیار
Dr. Cameron Brown is a Reader (equivalent to Associate Professor) at the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow. He specializes in developing digital design tools and strategies for pharmaceutical manufacturing. Brown joined Strathclyde in 2014 and has progressed through research associate, research fellow, and Chancellor's fellow positions. He currently coordinates the Drug Substance Manufacturing module for the Advanced Pharmaceuticals Manufacturing MSc program. Education: Brown holds a PhD in crystallization process characterization and a Chemical Engineering degree, both from Heriot-Watt University. Research Focus: His work centers on three primary areas: Hybrid modeling approaches : Integrating physics-based and data-driven models to enhance drug substance manufacturing efficiency Self-driving labs : Developing automated systems for drug substance process development with model-based experimental design Digital decision-making : Implementing coupled models through GenAI and LLMs for rapid pharmaceutical process development His research contributes to UN Sustainable Development Goals through improved medicine manufacturing sustainability. Publication Trends: Brown's recent articles focus on pharmaceutical crystallization, digital design methodologies, AI applications in manufacturing, and process optimization. His work demonstrates strong emphasis on translating computational models into industrial practice, particularly in continuous manufacturing and quality-by-design frameworks. Honors: Elected staff officer of British Association of Crystal Growth (2024) Research Leadership: Brown serves as Principal Investigator for PharmaCrystNet and co-investigator on multiple major initiatives including Digital Design and Manufacturing of Amorphous Pharmaceuticals, Future CMAC Manufacturing Hub, Accelerated Discovery and Development of New Medicines Prosperity Partnership, and ARTICULAR. He leads knowledge exchange projects with pharmaceutical companies and manages knowledge transfer partnerships. Professional Engagement: Brown is active in the Acceleration Consortium and serves on the committee of the British Association of Crystal Growth.









